Evidence map›Paper›PMID 32094421›Full record

ArticleScientific reports2020

Diversity of HLA Class I and Class II blocks and conserved extended haplotypes in Lacandon Mayans.

Rodrigo Barquera, Joaquin Zuniga, José Flores-Rivera, Teresa Corona, Bridget S Penman, Diana Iraíz Hernández-Zaragoza, Manuel Soler, Letisia Jonapá-Gómez, Kalyan C Mallempati, Petra Yescas and 14 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Genetic and genomic insights of the Comcáac people.Journal of community genetics · 2025
    Review
  3. Article
  4. Analysis ofFrontiers in genetics · 2024
    Article
  5. Article
  6. Differential Leukocyte Expression ofJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 12 institutions in 5 countries.

Rodrigo Barquera *Department of Archaeogenetics, Max Planck Institute for the Science of Human History (MPI-SHH), Jena, Germany.ORCID http://orcid.org/0000-0003-0518-4518
Joaquin Zuniga *Department of Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Mexico City, Mexico.ORCID http://orcid.org/0000-0002-7143-0281
José Flores-Rivera *Clinical Laboratory of Neurodegenerative Diseases, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Mexico City, Mexico.
Teresa Corona *Clinical Laboratory of Neurodegenerative Diseases, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Mexico City, Mexico.ORCID http://orcid.org/0000-0002-9324-229X
Bridget S Penman *University of Warwick, School of Life Sciences, Coventry, United Kingdom.
Diana Iraíz Hernández-Zaragoza *Laboratory of Molecular Genetics, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico.
Manuel SolerDepartment of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMSZ), Mexico City, Mexico.
Letisia Jonapá-GómezPublic Health State Laboratory for Chiapas, Tuxtla Gutierrez, Chiapas, Mexico.
Kalyan C MallempatiHistocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
Petra YescasDepartment of Neurogenetics and Molecular Biology, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Mexico City, Mexico.
Adriana Ochoa-MoralesDepartment of Neurogenetics and Molecular Biology, Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suárez", Mexico City, Mexico.
Konstantinos BarsakisHistocompatibility, Immunogenetics and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.
José Artemio Aguilar-VázquezClinical Analysis Laboratory, Unidad Médica Familiar (UMF) No. 23, Instituto Mexicano del Seguro Social (IMSS), Tuxtla Gutiérrez, Chiapas, Mexico.
Maricela García-LechugaDepartment of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMSZ), Mexico City, Mexico.
Michael MindrinosStanford Genome Technology Center, Palo Alto, CA, USA.
María YunisDepartment of Cancer Immunology and Virology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Luis Jiménez-AlvarezDepartment of Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Mexico City, Mexico.
Lourdes Mena-HernándezDepartment of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMSZ), Mexico City, Mexico.
Esteban OrtegaThe William Harvey Research Institute, Barts and London School of Medicine, Queen Mary University of London, London, United Kingdom.
Alfredo Cruz-LagunasDepartment of Immunology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Mexico City, Mexico.ORCID http://orcid.org/0000-0001-5487-5919
Víctor Hugo Tovar-MéndezDepartment of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMSZ), Mexico City, Mexico.
Julio GranadosDepartment of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMSZ), Mexico City, Mexico. julgrate@yahoo.com.
Marcelo Fernández-ViñaDepartment of Pathology, Stanford University, CA, USA. marcelof@stanford.edu.
Edmond YunisDepartment of Cancer Immunology and Virology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. edmond_yunis@dfci.harvard.edu.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXInstituto Nacional de Neurología y Neurocirugía · MXInstituto Nacional de Enfermedades Respiratorias · MXHarvard University · USMax Planck Institute for the Science of Human History · DEMexican Social Security Institute · MXNational Institute of Anthropology and History · MXQueen Mary University of London · GBStanford Blood Center · USStanford University · USUniversity of Crete · GRUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here we studied HLA blocks and haplotypes in a group of 218 Lacandon Maya Native American using a high-resolution next generation sequencing (NGS) method. We assessed the genetic diversity of HLA class I and class II in this population, and determined the most probable ancestry of Lacandon Maya HLA class I and class II haplotypes. Importantly, this Native American group showed a high degree of both HLA homozygosity and linkage disequilibrium across the HLA region and also lower class II HLA allelic diversity than most previously reported populations (including other Native American groups). Distinctive alleles present in the Lacandon population include HLA-A*24:14 and HLA-B*40:08. Furthermore, in Lacandons we observed a high frequency of haplotypes containing the allele HLA-DRB1*04:11, a relatively frequent allele in comparison with other neighboring indigenous groups. The specific demographic history of the Lacandon population including inbreeding, as well as pathogen selection, may have elevated the frequencies of a small number of HLA class II alleles and DNA blocks. To assess the possible role of different selective pressures in determining Native American HLA diversity, we evaluated the relationship between genetic diversity at HLA-A, HLA-B and HLA-DRB1 and pathogen richness for a global dataset and for Native American populations alone. In keeping with previous studies of such relationships we included distance from Africa as a covariate. After correction for multiple comparisons we did not find any significant relationship between pathogen diversity and HLA genetic diversity (as measured by polymorphism information content) in either our global dataset or the Native American subset of the dataset. We found the expected negative relationship between genetic diversity and distance from Africa in the global dataset, but no relationship between HLA genetic diversity and distance from Africa when Native American populations were considered alone.

Indexed as

Genetics, PopulationGenetic VariationHaplotypesLinkage DisequilibriumAdolescentAdultAfricaAllelesAmerican Indian or Alaska NativeFemaleGene FrequencyGenotypeGeographyHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-A AntigensHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-A AntigensHLA-B AntigensHLA-DRB1 Chains

Identifiers

PMID32094421
PMCPMC7039995
OpenAlexW3008542098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.